Tumor host relations. V. Nitrogen metabolism in Yoshida sarcoma-bearing rats. Reduction of growth rate and increase of survival time by administration of physiological doses of branched-chain amino acids.
The continuous administration of physiological doses of the branched-chain amino acids leucine, isoleucine, and valine (Leu-Ile-Val) to Yoshida sarcoma-bearing rats caused a significant increase in the survival time by 32% and a significant reduction of tumor size after 3 weeks of growth by 33%. The shift of the nitrogen balance to negative values during the cachectic stage was delayed but not prevented. On the average, less nitrogen (-47 mg/day) were lost by Leu-Ile-Val treated rats compared with untreated tumor-bearing animals (-91 mg N/day). It appeared that Leu-Ile-Val increased the synthesis of carcass proteins, while it left the proteolysis rate unchanged, since the excretion of urea and creatinine was unaffected by these amino acids. The daily excretion of alpha-ketoglutarate, which is correlated with tumor size during the early stage of growth, was decreased during the first 2 weeks by Leu-Ile-Val, but remained for a longer period on a high level than in untreated tumor bearers. The results point to an improvement of the metabolic resistance against carcass protein depletion of the tumor-bearing host by the administration of branched-chain amino acids.
D000596:Amino Acids / Q000494:pharmacology*; D000818:Animals; D001835:Body Weight; D004435:Eating; D005260:Female; D007532:Isoleucine / Q000494:pharmacology; D007656:Ketoglutaric Acids / Q000652:urine; D007930:Leucine / Q000494:pharmacology; D009584:Nitrogen / Q000378:metabolism*; D051381:Rats; D012517:Sarcoma, Yoshida / Q000378:metabolism* / Q000401:mortality; D014633:Valine / Q000494:pharmacology
D000596:Amino Acids; D007656:Ketoglutaric Acids; D007532:Isoleucine; D007930:Leucine; D014633:Valine; D009584:Nitrogen